Literature DB >> 32538468

Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors.

Silvia Uccella1, Stefano La Rosa2.   

Abstract

Mixed neuroendocrine - nonneuroendocrine neoplasms (MiNENs) of the digestive system represent a challenge for both pathologists and clinicians. Their nomenclature has changed several times, and their diagnostic criteria, classification and clinical behaviour have been matter of debate over the years. Although several attempts have been made to elucidate the pathogenesis and biology of MiNENs, some issues remain open. This review will provide: a historical background that helps in understanding the evolution of the concept and nomenclature of mixed neoplasms; a revision of the knowledge on this topic, including molecular aspects, to give the reader a comprehensive and practical overview on this challenging field of pathology; a focus on the diagnostic criteria and on the determination of prognostic and predictive factors; and a description of the different tumour types in the different sites of origin.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  MANEC; MiNEN; classification; mixed neuroendocrine and non-neuroendocrine neoplasm; prognosis

Mesh:

Year:  2020        PMID: 32538468     DOI: 10.1111/his.14178

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

Review 1.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

2.  Mixed neuroendocrine nonneuroendocrine neoplasms of the pancreas: a case report and literature review of pancreatic mixed neuroendocrine nonneuroendocrine neoplasm.

Authors:  Fei Wang; Xin Lou; Yi Qin; Xiaowu Xu; Xianjun Yu; Dan Huang; Shunrong Ji
Journal:  Gland Surg       Date:  2021-12

Review 3.  Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Authors:  Guido Rindi; Ozgur Mete; Silvia Uccella; Olca Basturk; Stefano La Rosa; Lodewijk A A Brosens; Shereen Ezzat; Wouter W de Herder; David S Klimstra; Mauro Papotti; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2022-03-16       Impact factor: 3.943

Review 4.  The classification of neuroendocrine neoplasms of the breast and its clinical relevance.

Authors:  Silvia Uccella
Journal:  Virchows Arch       Date:  2021-10-26       Impact factor: 4.064

Review 5.  Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms.

Authors:  Stefano La Rosa
Journal:  Endocr Pathol       Date:  2021-03-31       Impact factor: 3.943

Review 6.  An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.

Authors:  Anne Couvelard; Jérôme Cros
Journal:  Virchows Arch       Date:  2022-03-12       Impact factor: 4.064

Review 7.  Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach.

Authors:  Claudio Luchini; Giuseppe Pelosi; Aldo Scarpa; Paola Mattiolo; Deborah Marchiori; Roberta Maragliano; Fausto Sessa; Silvia Uccella
Journal:  Pathologica       Date:  2021-02

Review 8.  Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?

Authors:  Jingci Chen; Pengyan Wang; Ke Lv; Weixun Zhou
Journal:  Diagn Pathol       Date:  2021-11-20       Impact factor: 2.644

Review 9.  Mixed neuroendocrine-nonneuroendocrine neoplasms of the gastrointestinal system: An update.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

Review 10.  Classification of neuroendocrine neoplasms: lights and shadows.

Authors:  Stefano La Rosa; Silvia Uccella
Journal:  Rev Endocr Metab Disord       Date:  2020-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.